scorecardresearch
Add as a preferred source on Google
Thursday, February 26, 2026
TopicCAR- T therapy

Topic: CAR- T therapy

2nd ‘living drug’ against blood cancer gets regulatory nod. All about Qartemi, made in India

Sumi Sukanya Dutta -
Therapy will cost Rs 35 to 50 lakh. India sees around 1.20 lakh new blood cancer cases and over 70,000 deaths annually from leukemia, lymphoma & multiple myeloma.

On Camera

YourTurn

Opinion

Pew’s religious diversity study is producing perverse results

R Jagannathan -
Pew’s survey on religious diversity around the world is interesting, but simply lacks enough nuance to warrant serious consideration.

To trade coders for Legos, India needs a better deal

Joining Pax Silica is not all positives for India. We must guard strategic autonomy

Economy

In 1st budget under BJP mayor in 44 yrs, BMC hikes outlay to Rs 81k crore, focus on big-ticket infra

Purva Chitnis -
India's richest civic body’s outlay is 8.77% higher than last year’s, with the biggest allocation being made for infra growth. BMC also proposed an AI boost to its service delivery.

Defence

What to expect on the defence front as Modi embarks on Israel visit, second since 2017

Snehesh Alex Philip -
The two sides will sign a framework agreement on defence cooperation that will allow companies from both sides to collaborate deeper.

National Interest

No country is ever fully sovereign. Cold War era taught India its real meaning

Shekhar Gupta -
India’s fraught neighbourhood places multiple constraints on its strategic choices. It leaves no time to take a deep breath, lean back and reset.

Follow us

Copyright © 2025 Printline Media Pvt. Ltd. All rights reserved.